My best ASX stocks to invest $2,000 in right now

Brokers sees significant value in these beaten down stocks.

Key points
  • CSL is trading at a significant discount, with shares down nearly 40% due to concerns over CSL Behring’s slower margin recovery and potential tariffs, but the company’s robust fundamentals and strong demand for its therapies make it appealing for long-term growth.
  • WiseTech Global has seen a rare price pullback in 2025 despite its key role in global logistics, offering a solid investment opportunity with its resilient revenue model and growing importance in an increasingly complex freight sector.
  • Both CSL and WiseTech are viewed favourably by major brokers, with substantial price targets suggesting considerable upside, highlighting the current investment potential during their market downturns.

When markets get choppy, many investors sit on the sidelines waiting for conditions to get better.

But long-term wealth is built by doing the opposite, buying high-quality stocks when uncertainty drags their share prices lower.

Right now, two ASX giants have been sold off heavily in 2025, despite continuing to strengthen their underlying businesses.

If I had $2,000 to put to work today, these ASX stocks would be at the top of my list.

A group of businesspeople clapping.

Image source: Getty Images

CSL Ltd (ASX: CSL)

It is not often Australia's biotech champion trades at this kind of discount. CSL shares are down sharply this year, falling close to 40% from their peak as investors react to slower margin recovery at CSL Behring, uncertainty around the planned spin-off of Seqirus, and noise surrounding potential US tariffs.

But despite this, the underlying fundamentals remain strong. CSL continues to benefit from rising global demand for plasma-derived therapies, with long-term demographic and healthcare trends firmly in its favour. Its pipeline is expanding, its US manufacturing investment is progressing, and the company remains one of the most profitable and resilient healthcare businesses in the world.

Importantly, CSL's valuation has reset to levels not seen in a decade. At roughly 20x earnings, the stock is trading at a meaningful discount to its historical averages. Unsurprisingly, many major brokers now see significant upside, with price targets far above current levels.

For example, UBS has a buy rating and $275.00 price target on its shares, which implies potential upside of 50%.

WiseTech Global Ltd (ASX: WTC)

Another ASX stock that could be a great option for a $2,000 investment is WiseTech Global. It has also experienced a rare pullback in 2025, despite continuing to strengthen its position as one of the world's most important logistics software companies.

Its CargoWise platform is embedded across global supply chains, used by many of the largest freight forwarders and logistics operators across Europe, Asia and North America.

The company's recurring revenue model, sticky customer base, and history of disciplined acquisitions have made it one of the ASX's most consistent tech performers over the past decade. And with global freight complexity increasing, WiseTech's software is becoming more essential, not less.

Despite this, the share price has been volatile this year and that volatility offers an attractive entry point according to many brokers.

Morgans is one of them. It has a buy rating and $127.60 price target on the company's shares.

Motley Fool contributor James Mickleboro has positions in CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Colleagues checking out company's financial numbers on a laptop.
Blue Chip Shares

Woodside Energy vs Rio Tinto: Which ASX 200 stock is better value?

Woodside and Rio are both ASX blue chips, but which one looks better value right now?

Read more »

Woman and man at work looking at data on a tablet at work.
Blue Chip Shares

ANZ vs AMP: Which ASX blue chip is the better buy this month?

ANZ and AMP are both ASX financial giants—but which blue chip offers better value and growth right now?

Read more »

Person holding a blue chip.
Blue Chip Shares

Fortescue vs National Australia Bank: Which ASX blue chip is the better buy this month?

Fortescue vs National Australia Bank: Which one gets my nod as the better buy right now?

Read more »

Cheerful boyfriend showing mobile phone to girlfriend with a coffee mug in dining room.
Blue Chip Shares

Why I'd buy CBA and Coles shares in October

I take a closer look at two ASX shares I would consider putting fresh money into this month.

Read more »

Blue chip in a trolley with a man pushing it.
Blue Chip Shares

Commonwealth Bank vs BHP: Which ASX blue chip is the better buy in October?

Which company has the edge in my October ASX blue-chip comparison?

Read more »

Male hands holding Australian dollar banknotes, symbolising dividends.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These large businesses have a lot of positives.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Blue Chip Shares

CBA vs Telstra: Which ASX blue-chip is better for passive income?

Commonwealth Bank or Telstra for your next passive income buy? I compare yields, franking, and my top pick for income…

Read more »

Woman and man at work looking at data on a tablet at work.
Opinions

Buy, hold, sell: BHP, CSL, and Westpac shares

I take a closer look at how I would approach these three major ASX shares today.

Read more »